Physician profile
Jon Grace
NPI 1245573278
$9,038.13
in general payments reported to CMS, 2019-2025
13 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $399 · 2023: $6,285 · 2024: $1,816 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,520 · Travel and Lodging: $2,727 · Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,520.00 |
| Travel and Lodging | $2,726.59 |
| Food and Beverage | $1,268.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,838.77 | 2023-2025 | Ion, Da Vinci Surgical System, Da Vinci Sp |
| Glaxosmithkline, LLC. | $304.97 | 2021-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $296.44 | 2022-2025 | |
| Baxter Healthcare | $173.57 | 2022-2025 | Hillrom - Volara System, Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Blueprint Medicines Corporation | $120.90 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.27 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $60.72 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $45.85 | 2024-2025 | Dupixent |
| Genentech USA, INC. | $24.78 | 2022 | |
| Insmed, INC. | $20.87 | 2025 | Arikayce |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Mylan Specialty L.P. | $18.40 | 2022 | |
| Philips North America LLC | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Grace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.